Can I take lisinopril (ACE inhibitor) and losartan (angiotensin II receptor blocker) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Do Not Take Lisinopril and Losartan Together

You should not take lisinopril (an ACE inhibitor) and losartan (an ARB) at the same time—this combination is explicitly contraindicated by all major guidelines and the FDA drug label due to increased risks of kidney failure, stroke, and hyperkalemia without additional cardiovascular or renal benefits. 1, 2

Why This Combination Is Harmful

Evidence from Major Clinical Trials

The prohibition against combining ACE inhibitors with ARBs is based on strong evidence from two landmark trials:

  • ONTARGET trial: Demonstrated that dual blockade of the renin-angiotensin system with an ACE inhibitor plus ARB resulted in significantly increased rates of end-stage renal disease and stroke compared to monotherapy 1

  • VA NEPHRON-D trial: Specifically tested the combination of lisinopril plus losartan in diabetic patients with kidney disease and was stopped early because patients receiving both drugs experienced increased hyperkalemia and acute kidney injury without any additional benefit for preventing kidney disease progression or death 2

  • ALTITUDE trial: Confirmed these harms when testing dual renin-angiotensin system blockade, showing excess cases of end-stage renal disease and stroke 1

Specific Risks You Face

Hyperkalemia (dangerously high potassium): The combination dramatically increases your risk of life-threatening potassium elevations, particularly if you have diabetes or existing kidney disease 1, 3, 2

Acute kidney injury: Dual blockade causes more frequent and severe deterioration in kidney function compared to using either drug alone 3, 2

Hypotension and syncope: The combination causes excessive blood pressure lowering that can lead to dizziness, falls, and fainting 2

No added benefit: Despite these serious risks, the combination provides no improvement in cardiovascular outcomes or kidney disease progression beyond what a single agent achieves 3

What You Should Do Instead

Use Only One RAAS Blocker

Choose either lisinopril OR losartan—never both together. 1, 3

  • If you need better blood pressure control on a single agent, first optimize the dose of whichever drug you're taking (e.g., increase lisinopril up to 40 mg daily or losartan up to 100 mg daily) 4

  • Studies show that increasing the dose of a single ARB or ACE inhibitor is safer and nearly as effective as combining two RAAS blockers 4

Add Different Drug Classes for Better Control

If your blood pressure remains uncontrolled on an optimized dose of lisinopril or losartan, the preferred strategy is adding medications from different classes: 1, 3

  • Calcium channel blockers (like amlodipine)—this is the most preferred combination 1
  • Thiazide or thiazide-like diuretics (like chlorthalidone or hydrochlorothiazide) 1
  • Loop diuretics if you have fluid retention 3

These combinations are proven safe and effective, unlike the ACE inhibitor + ARB combination.

Critical Warnings

If You're Already Taking Both

Stop one of these medications immediately and contact your prescribing physician. Do not stop both at once without medical guidance, as abrupt withdrawal can cause rebound hypertension. 2

Special High-Risk Situations

The combination is particularly dangerous if you have: 3, 2

  • Chronic kidney disease (especially stage 4 with GFR <30 mL/min)
  • Diabetes
  • Heart failure
  • Volume depletion or dehydration

Monitor Carefully If Switching

When transitioning from one RAAS blocker to another (not combining them), check your kidney function and potassium levels within 1-2 weeks 3

Why Some Doctors Might Have Considered This

Older research from the early 2000s suggested the combination might reduce proteinuria more than monotherapy 5, 6, 7, 4. However, subsequent large-scale trials definitively proved that any modest reduction in protein in the urine does not translate to better kidney or heart outcomes and comes at the cost of serious adverse events 1, 3, 2. This is outdated practice that has been abandoned based on current evidence.

Related Questions

What is the recommended antihypertensive medication for a patient with a history of stroke and impaired renal (kidney) function?
How to manage a patient with lightheadedness on Bendroflumethiazide (thiazide diuretic) and losartan (angiotensin II receptor antagonist) with impaired renal function?
What is the recommended treatment for a 26-year-old patient with Diabetes Mellitus (DM) type 1, well-controlled blood sugar levels (Hemoglobin A1c (HbA1c) 5.0), and persistent proteinuria (2-3 grams, peaked at 4 grams), without diabetic retinopathy, who cannot tolerate Angiotensin-Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARBs) due to heartburn symptoms?
What is the most likely intervention to limit the progression of renal failure in a patient with a history of poststreptococcal glomerulonephritis (PSGN) and impaired renal function?
What are the next steps for a 56-year-old male with Chronic Kidney Failure (CKF), noncompliant with treatment, presenting with lower extremity edema and hypertension, currently on Carvedilol (Beta Blocker) 6.25 MG, Losartan Potassium (Angiotensin II Receptor Antagonist) 50 MG, and recently started on Lasix (Furosemide) 20mg twice daily?
What additional antihypertensive options are appropriate for a patient with resistant hypertension who is already taking hydrochlorothiazide, losartan, and clonidine?
In a healthy adult with normal renal function, how many hours after an oral 40 mL (≈20 mmol) potassium chloride dose will serum potassium rise enough to be detected on a basic metabolic panel?
In an adult trauma patient with hypotension from blunt or penetrating injury, what is the role and recommended dosing of isotonic crystalloid fluids?
What drug class does diltiazem belong to?
When is herpes zoster (shingles) contagious?
What patient education and monitoring schedule (including labs, DEXA scans, and follow‑up visits) should be provided for a postmenopausal woman with osteoporosis who is starting raloxifene (Evista)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.